Normal-Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple

Xinli Wang1,2, Huiying Wang1,3, Zhizheng Zhuo4

  • 1Department of Radiology, First Central Hospital of Tianjin Medical University, Tianjin, China.

Abstract

Insights

Multiple sclerosis (MS) patients exhibit lower cerebral venous oxygen saturation (SvO2), indicating hypoxia. This hypoxia is linked to white matter damage, increasing lesion burden and clinical disability.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Multiple Sclerosis (MS) is a chronic demyelinating disease affecting the central nervous system.
  • Understanding the relationship between cerebral hypoxia and white matter integrity is crucial for MS progression monitoring.

Purpose of the Study:

  • To investigate the impact of cerebral hypoxia and Normal-Appearing White Matter (NAWM) integrity on MS lesion burden and clinical outcomes.
  • To explore the potential of cerebral venous oxygen saturation (SvO2) and NAWM integrity as biomarkers for MS progression.

Main Methods:

  • Quantitative Susceptibility Mapping (QSM) to measure SvO2 in deep cerebral veins.
  • Diffusion Tensor Imaging (DTI) and Neurite Orientation Dispersion and Density Imaging (NODDI) to assess white matter microstructure (lesions and NAWM).
  • Partial correlation and mediation analyses to examine associations between imaging biomarkers and clinical indicators in MS patients and healthy controls.

Main Results:

  • MS patients showed significantly lower SvO2 in the internal cerebral vein compared to healthy controls.
  • Extensive microstructural disruptions were observed in both white matter lesions and NAWM of MS patients.
  • NAWM microstructural integrity (MD and ODI) significantly correlated with ICV SvO2.
  • Mediation analysis revealed that deep brain white matter hypoxia (ICV SvO2) contributes to greater lesion burden and clinical disability through NAWM damage.

Conclusions:

  • Lower cerebral SvO2 in MS patients is associated with microstructural alterations in NAWM.
  • A pathway exists where reduced SvO2 leads to increased lesion burden and worse clinical scores via NAWM damage.
  • SvO2 and NAWM integrity show potential as biomarkers for monitoring MS progression, requiring further longitudinal validation.